BARACLUDE 1 mg/1 (Entecavir TABLET, FILM COATED) 1 mg/1

Baraclude 1 mg is an antiviral medication used to manage chronic hepatitis B. This film-coated tablet helps control the virus in adults and children over 2 years old.

Strength

1 mg/1

Pack Size

1 BOTTLE in 1 CARTON (0003-1612-12) / 30 TABLET, FILM COATED in 1 BOTTLE

Manufacturer / TM Owner

E.R. Squibb & Sons, L.L.C.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Baraclude 1 mg is primarily used to treat chronic hepatitis B virus (HBV) infection. It works by reducing the amount of virus in the body, which can help manage the condition over time. This medication is often prescribed for long-term use to control the virus and prevent complications associated with chronic HBV.

Side Effects

Common effects of Baraclude 1 mg may include headaches, tiredness, and stomach discomfort. Some users might experience dizziness or mild nausea. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Precautions & Warnings

Baraclude 1 mg should be handled with care, especially for those with kidney problems or a history of liver disease. It is important to follow the prescribed dosage and not to share the medication with others. Always store the tablets in a cool, dry place away from direct sunlight.

Avoid Interactions

Baraclude 1 mg may interact with other medications, including certain antiviral drugs and immunosuppressants. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.

Frequently Asked Questions

Baraclude 1 mg is used to treat chronic hepatitis B virus (HBV) infection by reducing the amount of virus in the body.

Store Baraclude 1 mg in a cool, dry place away from direct sunlight and out of reach of children.

Baraclude 1 mg may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Common side effects may include headaches, tiredness, stomach discomfort, dizziness, and mild nausea.

Baraclude 1 mg can be used in children over 2 years old, but it should be administered under the guidance of a healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.